e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung cancer in never smokers. An update of the Lung Cancer Risk Factors in Never Smokers Study (LCRINS)
M. Torres Duran (Vigo (Pontevedra), Spain)
Source:
International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Session:
Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Session type:
Thematic Poster
Number:
4254
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Torres Duran (Vigo (Pontevedra), Spain). Lung cancer in never smokers. An update of the Lung Cancer Risk Factors in Never Smokers Study (LCRINS). 4254
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST)
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018
Consequences of Lung Cancer: Mortality and Comorbidity in Danish Patients with Lung Cancer 1998-2010
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
The Role Of TGF-ß in Lung Cancer Development in COPD Patients
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Lung cancer in women: Is it different?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Awareness of lung cancer symptoms and risk factors
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014
Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
Survival among never and ever smokers with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) study
Source: Annual Congress 2010 - Epidemiology of lung cancer
Year: 2010
Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Use of cannabis and primary lung cancer
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014
Bronchogenic carcinoma between never-smoker and smoker patients: What are the difference?
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
EGFR-mutated lunge cancer in a general Norwegian population
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Radiation pneumonitis; early diagnosis and associated factors
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Causes of Hospitalization and Mortality in Lung Cancer Patients
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
Lung Micobiome in Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Relationship between risk factors for lung cancer and tumor size
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Comparing smokers and non-smokers attending a rapid access lung cancer clinic
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014
Lung cancer in never smokers. A survival analysis in a radon prone area
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Metabolomic analysis of serum samples from patients with lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept